IVAX Diagnostics, Inc., through its subsidiaries, engages in the development, manufacture, and marketing of diagnostic test kits and automated systems that are used to aid in the detection of disease markers primarily in the areas of autoimmune and infectious diseases. The companys tests are based on enzyme linked immunosorbent assay (ELISA) technology, a clinical testing methodology. It offers laboratory instruments, including Mago 4, Mago Plus, and Aptus systems that perform the tests in an automated mode; and develops, manufactures, and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers to produce autoimmune diagnostic kits. IVAX Diagnostics sells its products to hospitals, reference laboratories, clinical and research laboratories, and pharmaceutical and biotechnology companies, as well as to other commercial companies that manufacture diagnostic products primarily in the United States and Europe. The company was founded in 1980 and is headquartered in Miami, Florida. As of September 1, 2010, IVAX Diagnostics Inc. operates as a subsidiary of ERBA Diagnostics Mannheim GmbH.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• No BuyIns.Net Alerts Available for IVD